Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests
Evidence suggests that allogenic hematopoietic cell transplantation (HCT) improves overall survival in patients with myelodysplastic syndrome (MDS), a serious blood disorder, when compared with best available supportive care. ...
Aug 23, 2023
0
3